Tom Gayner acquired 2.15 Million Novo Nordisk - ADR shares worth $264 Million. That's 2.76% of their equity portfolio (9th largest holding). The first Novo Nordisk - ADR trade was made in Q4 2009. Since then Tom Gayner bought shares four more times and sold shares on twelve occasions. The stake costed the investor $99 Million, netting the investor a gain of 167% so far.